Latest Articles

Blog Hero
Uncovering the Truth of Medicare Advantage
 

This article discusses the ongoing privatization of Medicare and how private insurers are making significant profits through systematic overbilling and opposition to measures aimed at stopping the practice. It focuses on Humana, a prominent health insurance...

A Closer Look at the DSCSA
 

The Drug Supply Chain Security Act (DSCSA) was enacted by the U.S. Congress on November 27, 2013, and aims to build a comprehensive, interoperable system by 2023 to identify and trace prescription drugs as they are distributed in the United States. The four core...

The Road to Automated Data Exchange in Pharma
 

The pharmaceutical industry needs an automated data exchange to achieve unit-level traceability as required by the Drug Supply Chain Security Act (DSCSA) by its 2023 deadline.

The DSCSA aims to enhance product legitimacy verification, improve recall efficiency, and...

New Non-Hormonal Medication Approved for Hot Flashes
 

The FDA recently approved a new medication called Veozah (fezolinetant) for the treatment of moderate to severe hot flashes in menopausal women. Hot flashes are characterized by sudden waves of intense heat, followed by sweating and sometimes chills. Veozah is an...

The Growing Power of CVS and UnitedHealth
 

In April, CVS Health, CEO Karen Lynch celebrated the acquisition of Oak Street Health, a primary care company specializing in treating Medicare-eligible patients. CVS has been expanding its presence in the healthcare industry by acquiring various companies,...

Community Pharmacies as Care Access Solutions
 

A recent analysis published in the Journal of the American Pharmacists Association highlights the expanding role of community pharmacies in filling patient care access gaps.

With nearly 90% of Americans living within five miles of a community pharmacy, these...

Walgreens Remains Committed to Clinical Trials
 

Walgreens remains committed to conducting clinical trials despite CVS Health's decision to wind down its clinical trial services by the end of 2024. Both companies launched their clinical trial businesses in the last two years when the US FDA was seeking to enroll...

UC San Francisco to Offer Pharmacogenetic Testing
 

UC San Francisco academic medical center will be the first in California to offer pharmacogenetic testing that helps pharmacists tailor medications and dosages to a patient's genetic makeup. The testing service will identify variations in 15 genes that affect...